|
IM-MV 15-012_007
|
AMC
|
Testing CTL019 in clinical trials with patients with B cell malignancies
|
26-02-2020
|
Vergunning verleend
|
|
IM-MV 16-004_008
|
AMC
|
Testing the safety and efficacy of KTE-C19 in patients with refractory or relapsed B-cell malignancies
|
26-02-2020
|
Vergunning verleend
|
|
IM-MV 19-022_000
|
LUMC
|
A phase II safety, dose finding and feasibility trial of MB-CART2019.1 in patients with relapsed or resistant B-NHL
|
|
Vergunning verleend
|
|
IM-MV 19-024_000
|
Stichting Katholieke Universiteit
|
EXPLORE: A Phase II, masked multicentre, randomised study to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration
|
|
Ontwerpbesluit genomen
|
|
IM-MV 20-001_000
|
UMCG
|
Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy.
|
|
Ontwerpbesluit genomen
|
